Dimensional Fund Advisors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,020	Closed	-$485K	–	3448
2020 Q4	$485K	Sell	21,020 -548	-3%	-$12.6K	﹤0.01%	3095
2020 Q3	$219K	Buy	+21,568	New	+$219K	﹤0.01%	3194